Olink Holding AB (publ) (OLK)
Market Cap | 2.38B |
Revenue (ttm) | 125.65M |
Net Income (ttm) | -26.25M |
Shares Out | 119.10M |
EPS (ttm) | -0.21 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 256,391 |
Open | 19.66 |
Previous Close | 19.96 |
Day's Range | 19.50 - 20.04 |
52-Week Range | 8.39 - 26.47 |
Beta | n/a |
Analysts | Buy |
Price Target | 23.46 (+17.59%) |
Earnings Date | Feb 21, 2023 |
About OLK
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Sig... [Read more]
Financial Performance
In 2021, OLK's revenue was $94.97 million, an increase of 75.66% compared to the previous year's $54.07 million. Losses were -$38.34 million, 465.5% more than in 2020.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for OLK stock is "Buy." The 12-month stock price forecast is $23.46, which is an increase of 17.59% from the latest price.
News

Why Is Olink (OLK) Stock Down 17% Today?
Olink (NASDAQ: OLK) stock is falling on Thursday as investors react to the pricing of a public offering of the proteomics company's shares. The offering prices 5,831,028 American Depository Shares ( ...

Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares
Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 5,831,028 American Depositary S...

Olink Holding AB (publ) launches public offering of American Depositary Shares
Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the launch of a public offering of 5,831,028 American Depositary Sh...

Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023
UPPSALA, Sweden, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink” or the “Company”) (Nasdaq: OLK), today announced preliminary unaudited revenue for the fourth quarter and year ended...

Olink to participate in the 41st Annual JP Morgan Healthcare Conference
UPPSALA, Sweden, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 41st Annual JP Morgan Healthcare Conference.

5 Winning Medical Product Stocks That Still Have Room to Run
Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain f...

DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS
Creates a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis to support drug and diagnostic development HUNTSVILLE, Ala. , Dec. 14, 2022 /PRN...

Is Olink Holding (OLK) Outperforming Other Medical Stocks This Year?
Here is how Olink Holding AB publ Sponsored ADR (OLK) and Oncolytics Biotech Inc. (ONCY) have performed compared to their sector so far this year.

5 Best Stocks to Invest in for Solid Earnings Acceleration
Invest in stocks like MacroGenics (MGNX), NerdWallet (NRDS) & LivePerson (LPSN) at the moment for superb earnings acceleration.

Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award
UPPSALA, Sweden, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the 2022 winner of the young researchers' award, Novelties in Biomarkers, Maria Martin-Gra...

Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification
UPPSALA, Sweden, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink ® Flex, a fully flexible made-to-order product to select...

Olink Holding AB publ Sponsored ADR (OLK) Reports Q3 Loss, Tops Revenue Estimates
Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead...

Olink reports third quarter 2022 financial results
UPPSALA, Sweden, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter of 2022.

Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology
UPPSALA, Sweden, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the achievement of more than one thousand peer-reviewed publications citing the use o...

Olink Holding AB publ Sponsored ADR (OLK) Moves to Buy: Rationale Behind the Upgrade
Olink Holding AB publ Sponsored ADR (OLK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ...

7 Short-Squeeze Stocks to Buy for Contrarian Investors
Short-squeeze stocks offer tremendous upside potential for people who laugh in the face of danger. Fundamentally, the concept involves betting against the pessimistic crowd with the aim of sparking a ...

Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs
UPPSALA, Sweden, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it has entered into an agreement with Discovery Life Sciences™ (Discovery) to e...

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE
HUNTSVILLE, Ala. , Sept. 20, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) a...

Multi-omics service provider Sequanta completes extended concordance validation of Olink® Target 48/96 and Olink® Explore
UPPSALA, Sweden, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfull...

Olink strengthens management team for continued leadership in the modern proteomics era
UPPSALA, Sweden, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced several appointments in its leadership structure.

Olink to participate in September investor conferences
UPPSALA, Sweden, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor conferences:

Olink Holding AB publ Sponsored ADR (OLK) Reports Q2 Loss, Tops Revenue Estimates
Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 69.23% and 3.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for ...

Olink to report second quarter 2022 financial results on August 11, 2022
UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the market op...

Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight
UPPSALA, Sweden, June 28, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the release of Olink® Analyze 3.1. Olink® Analyze is an R software package, a collection of fun...

UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research
UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) announced that a publication describing the early findings of proteomics research conducted by the UK Biobank P...